Research Papers

25 of 207 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.
Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The prognostic importance of the angiotensin II/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infection.
Amezcua-Guerra LM; Del Valle L; González-Pacheco H; Springall R; Márquez-Velasco R; Massó F; Brianza-Padilla M; Manzur-Sandoval D; González-Flores J; García-Ávila C; Juárez-Vicuña Y; Sánchez-Muñoz F; Ballinas-Verdugo MA; Basilio-Gálvez E; Paez-Arenas A; Castillo-Salazar M; Cásares-Alvarado S; Hernández-Diazcouder A; Sánchez-Gloria JL; Tavera-Alonso C; Gopar-Nieto R; Sandoval J.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.
Stanford GE; Jones M; Charman SC; Bilton D; Usmani OS; Davies JC; Simmonds NJ.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observation…
Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United S…
Averell CM; Laliberté F; Germain G; Duh MS; Rousculp MD; MacKnight SD; Slade DJ.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical characteristics in adult patients with somatic cough syndrome.
Lai K; Peng W; Zhan W; Xie JX; Tian J; Zuo XP; Long L; Tang JM; Pan JY; Jiang M; Zhong NS.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled t…
Casale TB; Burnette A; Bourdin A; Howarth P; Hahn B; Stach-Klysh A; Khurana S.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
Müllerová H; Marshall J; de Nigris E; Varghese P; Pooley N; Embleton N; Nordon C; Marjenberg Z.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Effects of expressive art therapy on health status of patients with chronic obstructive pulmonary disease: a community-…
Zuo X; Lou P; Zhu Y; Chen B; Zhu X; Chen P; Dong Z; Zhu X; Li T; Zhang P.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Treatment of peripheral bronchopleural fistula with interventional negative pressure drainage.
Li X; Wang S; Yin M; Li X; Qi Y; Ma Y; Li C; Wu G.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave w…
Gu B; Yao L; Zhu XY; Zou T; Feng YJ; Yan JY; Zhang JP; Tang PJ; Chen C.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of physical training on cytokine expression in CD4+ T lymphocytes in subjects with stable COPD.
Uzeloto JS; de Toledo-Arruda AC; Silva BSA; Braz AMM; de Lima FF; Grigoletto I; Ramos D; Golim MA; Ramos EMC.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Two-day <i>versus</i> seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.
Messous S; Trabelsi I; Bel Haj Ali K; Abdelghani A; Ben Daya Y; Razgallah R; Grissa MH; Beltaief K; Mezgar Z; Belguith A; Bouida W; Boukef R; Boubaker H; Msolli MA; Sekma A; Nouira S.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained ch…
Nguyen AM; Schelfhout J; Muccino D; Bacci ED; La Rosa C; Vernon M; Birring SS.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Importance of allergen-environment interactions in epidemic thunderstorm asthma.
Hughes KM; Price D; Suphioglu C.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected p…
Maincent C; Perrin C; Chironi G; Baqué-Juston M; Berthier F; Paulmier B; Hugonnet F; Dittlot C; Farhad RL; Renvoise J; Serrano B; Nataf V; Mocquot F; Keita-Perse O; Claessens YE; Faraggi M.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-a…
Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.
Michalski TA; Pszczola J; Lisowska A; Knapp M; Sobkowicz B; Kaminski K; Ptaszynska-Kopczynska K.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Caregiver burden in cystic fibrosis: a systematic literature review.
Daly C; Ruane P; O'Reilly K; Longworth L; Vega-Hernandez G.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
High-flow nasal cannula <i>versus</i> noninvasive ventilation in patients with COVID-19: a systematic review and meta-a…
He Y; Liu N; Zhuang X; Wang X; Ma W.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis.
Nash EF; Choyce J; Carrolan V; Justice E; Shaw KL; Sitch A; Mistry H; Whitehouse JL.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Lung transplantation for severe COVID-19-related ARDS.
Ko RE; Oh DK; Choi SM; Park S; Park JE; Lee JG; Kim YT; Jeon K.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination pro…
Hackner K; Stadler A; Schragel F; Klamminger V; Ghanim B; Varga A; Errhalt P.
Ther Adv Respir Dis (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Digital healthcare in COPD management: a narrative review on the advantages, pitfalls, and need for further research.
Watson A; Wilkinson TMA.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Lung deposition of inhaled once-daily long-acting muscarinic antagonists <i>via</i> standard jet nebulizer or dry powde…
Crater GD; Johnson K; Ward J; Backer J.
Ther Adv Respir Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared